Wesley Research Institute
Donate
Now

This essential project will evaluate the utility and impact of incorporating amyloid PET scans in diagnosing Alzeheimer’s disease. 

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Alzheimer's Disease (AD)

Study location

The Wesley Hospital

Study type

Investigator Initiated

Lead investigator

  • A/Prof David Wong

Experienced investigator

  • Dr Sepinoud Firouzmand

About this research project

The prevalence of Alzheimer’s disease in Australia is predicted to double in the next 20 years. The introduction of two newly approved medications offers hope for patients and highlights the need for early and accurate diagnosis. While functional diagnostic imaging, such as FDG PET/CT scans, have provided advantages over more invasive methods, they lack efficacy in diagnosing those with atypical presentations and at earlier stages (uncertain/equivocal cases). Recently, the amyloid PET/CT scan, targeting the disease’s hallmark (amyloid β plaques) has shown promise in diagnosing uncertain cases in international studies. Therefore, the primary objective of this study is to evaluate the added value of amyloid PET scans in reaching a final diagnosis in a subgroup of cases where the final diagnosis remains uncertain following the clinical and FDG-PET assessments. Such evidence could play a fundamental role in the revision of diagnostic guidelines in Australia and consequently in changing patient management plans. 

Latest News

Deep Dive: Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious, often misunderstood condition, characterised by abnormally high blood pressure in the arteries of the lung. Left untreated, it can lead to right heart failure and significantly reduce a person’s quality of life.

Clinical Trials Explained:  What to Expect and Why They’re Safer and More Valuable Than You Think

The idea of taking part in a clinical trial can feel a bit overwhelming. We're created this guide to help take the mystery out of clinical trials and show why they matter more than ever.

Living with FSHD: A Personal Journey of Strength, Hope, and Family

Meet Leona Luke: a 46-year-old mum from the Gold Coast. While her life seems like it’s all about family and fulfilling her everyday roles, Leona’s journey has been anything but typical. Leona was diagnosed with Facioscapulohumeral Muscular Dystrophy (FSHD), a progressive genetic disorder that weakens muscles over time.
1 2 3 25
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram